2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Metastasis directed radiotherapy (MDRT): new trials by email Literature Review of Metastasis directed radiotherapy (MDRT) trials Research Report on Metastasis directed radiotherapy (MDRT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) Androgen deprivation therapy (ADT), Androgen receptor signaling inhibitor (ARSI), Local Therapy: Radical Prostatectomy (RP) or Radiotherapy (RT) - Prostate Cancer, Malignant Neoplasm of Prostate | Phase 2 | Recruiting | Case Comprehensive Cancer Center | 200 | 2024-07-01 | 2026-09-15 |
| Radiotherapy to Consolidate Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate) Metastasis directed radiotherapy (MDRT), no MDRT - Prostate Cancer Metastatic | Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 80 | 2022-12-30 | 2026-09-08 |
Case Comprehensive Cancer Center (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1)
Canada (1) · United States (1)
Angela Y Jia, MD, PhD (1) · Daniel E Spratt, MD (1)
U01CA257638 (1)